Investors looking for large-cap growth exposure often come across two actively managed ETFs that appear to target similar results: CGGR and TCHP. Both aim for long-term capital growth by focusing on U.S. companies with strong earnings potential, yet their approaches diverge in meaningful ways. CGGR, managed by Capital Group, uses a multi-manager setup for broader diversification. TCHP, from T. Rowe Price, takes a more concentrated stance on a select group of blue-chip growth names. Examining the differences helps clarify how costs, holdings, and sector weights influence performance and positioning.
CGGR launched in February 2022 as an actively managed ETF seeking capital growth across U.S. companies of varying sizes. Multiple portfolio managers each handle a portion of the fund, which helps spread stock-selection decisions. The portfolio typically includes around 100 holdings, with the top 10 making up about 40% of assets.
Leading positions feature META, NVDA, MSFT, AVGO, and TSLA, along with V, GOOGL, AMZN, and LLY. Information technology leads at roughly 40%, followed by communication services, healthcare, and consumer discretionary in the low-to-mid teens. The fund also maintains notable exposure to mid- and small-cap names, often over 20%, which distinguishes it from many peers. Its expense ratio stands at 0.39%.
TCHP began trading in August 2020 as an actively managed, semi-transparent ETF. It commits at least 80% of assets to blue-chip growth companies with strong market positions and earnings potential. Classified as non-diversified, the fund holds a tighter lineup of roughly 55–75 names.
Top holdings center on NVDA (historically near 15%–17%), MSFT, AAPL, AMZN, GOOG, AVGO, and META, with the top 10 often exceeding 55% of assets. Information technology makes up close to half the portfolio, with communication services and consumer discretionary adding about a third more. This focused, tech-weighted approach leads to higher beta and greater concentration risk. The expense ratio is 0.57%.
Both ETFs align with the artificial-intelligence and cloud-computing trends that have shaped markets recently. Strong demand for semiconductors and data-center infrastructure has supported earnings at shared holdings such as NVDA, MSFT, and AVGO. At the same time, heavy exposure to these areas leaves the funds sensitive to interest-rate shifts, valuation changes, and any move away from mega-cap growth. Additional factors like regulatory pressures on large tech platforms and semiconductor supply issues also affect positioning.
Over recent cycles, TCHP has tended to magnify both gains and losses in the large-cap growth space due to its heavier technology weighting and concentration in names like NVDA. This can deliver stronger results when mega-cap tech leads but larger declines when sentiment changes. CGGR, on the other hand, has shown more measured volatility thanks to its wider sector spread and mid-cap exposure. Its lighter weighting in the biggest index names and allocations to healthcare, financials, and industrials offer some buffer during rotations. Choosing between them comes down to balancing concentrated momentum with diversified stability. I also checked sector weights using Tickeron’s AI Screener to compare the two side by side.
In my own analysis process, I regularly turn to Tickeron’s AI Screener to quickly filter ETFs by factors like sector allocation, expense ratios, and concentration levels. It surfaces relevant comparisons efficiently and helps confirm structural differences without manual number crunching. This tool has become a standard part of how I evaluate options like CGGR and TCHP before forming a view.
From what I see in the structural details, Tickeron’s AI points toward CGGR as the stronger choice here. The edge comes from its lower expense ratio of 0.39% compared with 0.57%, wider diversification across about 100 holdings versus a much tighter portfolio, and reduced exposure to any single stock or sector. While TCHP delivers more direct, higher-beta access to mega-cap technology momentum, CGGR’s balanced allocations, multi-manager approach, and full transparency offer a steadier base across different market conditions. Outcomes are never certain, and investors should consider their own comfort with volatility and concentration levels.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
TCHP moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TCHP as a result. In 55 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for TCHP turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 39 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
The 10-day moving average for TCHP crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCHP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for TCHP entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TCHP's RSI Indicator exited the oversold zone, 30 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCHP advanced for three days, in 294 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
TCHP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows